Importantly, the median time to development of SCC in patients with a history of prostatic adenocarcinoma is approximately 1825 months from prostatic adenocarcinoma diagnosis, but ranges widely from a few months to several years.

Artrial fibrillation is characterized by weakness, palpitations, reduced ability to exercise, chest pain, shortness of breath, dizziness, confusion, fatigue, lightheadedness, and chest pain.

Some procedures for atrial fibrillation treatments include catheter ablation, maze procedure, and atrioventricular node ablation, among others.